Patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 should not use these medications
At Set Point Medical Weight Loss Clinic, we provide proper guidance to help clients explore treatment options like tirzepatide
Additionally, 85%, 89%, and 91% of participants in the 5 mg, 10 mg, and 15 mg tirzepatide groups, respectively, achieved a 5% or more weight reduction, while only 35% of those on placebo did
You feel full longer, which helps reduce cravings and the urge to eat
These reductions were accompanied by significant body weight loss, confirming a robust pharmacodynamic response